HRAS and head and neck squamous cell carcinoma: Indeed, genomic clustering suggests that HRAS mutations define a unique subset of HNSCC, characterized in most cases by coincident loss of function mutations in caspase 8 and enrichment for absence (near-mutual exclusivity) of TP53 mutations [40,55,63].